Publication | Closed Access

Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice

InflammationRheumatologyIl-1 Receptor AntagonistAnti-inflammatoryRheumatoid DisorderAutoimmune DiseaseMedicineImmunologyAutoimmunityInflammatory Rheumatic DiseaseDisease ActivityPharmacologyRheumatoid ArthritisAdenoviral Delivery